Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Sulham

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of the American College of Emergency Physicians Open|March 28, 2022
Descriptive epidemiology and outcomes of emergency department visits with complicated urinary tract infections in the United States, 2016-2018Marya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
BMC Infectious Diseases|February 9, 2021
Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013-2018: a retrospective cohort studyMarya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2020
Antimicrobial Susceptibility and Cross-Resistance Patterns among Common Complicated Urinary Tract Infections in U.S. Hospitals, 2013 to 2018Marya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Open Forum Infectious Diseases|January 17, 2022
Descriptive Epidemiology and Outcomes of Hospitalizations With Complicated Urinary Tract Infections in the United States, 2018Marya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
BMC Infectious Diseases|April 19, 2017
Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsisMarya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Critical Care (London, England)|July 16, 2016
Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsisMarya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Antimicrobial Resistance and Infection Control|December 12, 2017
30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort studyMarya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Infection Control and Hospital Epidemiology|August 1, 2018
Development and validation of a bedside instrument to predict carbapenem resistance among gram-negative pathogens in complicated urinary tract infectionsMarya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Chest|January 28, 2019
A Novel Algorithm to Analyze Epidemiology and Outcomes of Carbapenem Resistance Among Patients With Hospital-Acquired and Ventilator-Associated Pneumonia: A Retrospective Cohort StudyMarya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Antibiotics (Basel, Switzerland)|January 25, 2025
Comparative Outcomes of Meropenem-Vaborbactam vs. Ceftazidime-Avibactam Among Adults Hospitalized with an Infectious Syndrome in the US, 2019-2021Marya D Zilberberg, Brian H Nathanson, Mark A Redell, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of the American College of Emergency Physicians Open|March 28, 2022
Descriptive epidemiology and outcomes of emergency department visits with complicated urinary tract infections in the United States, 2016-2018Marya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
BMC Infectious Diseases|February 9, 2021
Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013-2018: a retrospective cohort studyMarya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2020
Antimicrobial Susceptibility and Cross-Resistance Patterns among Common Complicated Urinary Tract Infections in U.S. Hospitals, 2013 to 2018Marya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Open Forum Infectious Diseases|January 17, 2022
Descriptive Epidemiology and Outcomes of Hospitalizations With Complicated Urinary Tract Infections in the United States, 2018Marya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
BMC Infectious Diseases|April 19, 2017
Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsisMarya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Critical Care (London, England)|July 16, 2016
Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsisMarya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Antimicrobial Resistance and Infection Control|December 12, 2017
30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort studyMarya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Infection Control and Hospital Epidemiology|August 1, 2018
Development and validation of a bedside instrument to predict carbapenem resistance among gram-negative pathogens in complicated urinary tract infectionsMarya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Chest|January 28, 2019
A Novel Algorithm to Analyze Epidemiology and Outcomes of Carbapenem Resistance Among Patients With Hospital-Acquired and Ventilator-Associated Pneumonia: A Retrospective Cohort StudyMarya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Antibiotics (Basel, Switzerland)|January 25, 2025
Comparative Outcomes of Meropenem-Vaborbactam vs. Ceftazidime-Avibactam Among Adults Hospitalized with an Infectious Syndrome in the US, 2019-2021Marya D Zilberberg, Brian H Nathanson, Mark A Redell, et al.
Pageof 2